Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 27,402

Document Document Title
WO/2022/023762A1
The present invention relates to compounds for use in the delaying of labour and/or inhibition of uterine contractions in pre-term pregnant subjects. Such compounds include selective prostaglandin EP2 receptor agonists which specifically...  
WO/2022/025204A1
The present disclosure provides an anti-EpoR peptide for use in the treatment of a disease such as cancer. In the description, a peptide which has the structure: -[SCHFGPLTWVCK]- and which is intended to be used for antagonizing an Epo h...  
WO/2021/249913A9
The present invention relates to Map4K1 inhibitors of formula (I), to pharmaceutical compositions and combinations comprising the compounds according to the invention, and to the prophylactic and therapeutic use of the inventive compound...  
WO/2022/017515A1
Provided in the present application are a diarylamine compound, a preparation method therefor and an application thereof. The compound has a structure represented by formula 1; R1 is selected from an alkyl group of C1-12, an alkoxy group...  
WO/2022/016752A1
An endometriosis lesion-targeted nano-delivery system, and a preparation method therefor and the use thereof. The delivery system comprises a hydrophobic inner core, which is located at the center, a lipid monomolecular layer around the ...  
WO/2022/016375A1
An ectopic endometrium recognition polypeptide, and a derivative and the use thereof, which belong to the field of medical cell biology. The ectopic endometrium recognition polypeptide comprises a combination of one or more of the follow...  
WO/2022/018716A1
Provided herein are an intravaginal delivery device comprising a plurality of distinct hydrogel layers, and methods of using same for treating a disease or disorder.  
WO/2022/013430A1
The present invention relates to new glycolipids derivatives of Formula (I) and their use in the treatment of diseases related with a deregulation of the expression and/or activity of SK3 ion channels. The present invention further relat...  
WO/2022/014654A1
The present invention provides: a therapeutic and/or prophylactic agent for African swine fever (ASF) that contains 5-aminolevulinic acid (ALA), a derivative thereof or a salt of the same; and a therapeutic and/or prophylactic method for...  
WO/2022/009170A1
The present invention relates to a novel isolated and characterised bacterial strain belonging to the species Lacticaseibacillus rhamnosus, to compositions thereof and to the use thereof in the treatment of genitourinary infections and/o...  
WO/2022/009863A1
The present invention relates to a treatment agent for various diseases of the nervous system and mental illnesses which contains the compound represented in formula (1) or a pharmaceutically acceptable salt thereof as the active compone...  
WO/2022/008707A1
The present invention refers to a biomass of T. chuii and a pharmaceutical composition comprising a biomass of T. chuii for use in the treatment of infertility in a male subject. It also refers to a method for increasing the quality of t...  
WO/2022/002336A1
The present invention relates to a method for determining a likely effect of a treatment to improve male fertility using an antagonist or inhibitor of RANKL based on levels of AMH or Inhibin B in a biological sample such as serum or semi...  
WO/2022/003259A1
An automated system (100) for processing physiological parameter measurements for providing an assessment of a medical risk. It comprises a model (106) previously built by machine learning to provide an idiopathic infertility score (S) o...  
WO/2021/261490A1
The present invention addresses the problem of acquiring a promoter that promotes the synthesis and secretion of testosterone without any side effects. The present inventors searched for materials having significantly high ability to pro...  
WO/2021/261341A1
[Problem] To provide a new use for a processed product of a plant of the genus Phyllanthus. [Solution] Provided are a composition for inhibiting PDE5 activity, a composition for improving erectile function, and a composition for improvin...  
WO/2021/260546A1
Herein described is a composition comprising a combination or mixture of hyaluronic acid and/or a salt thereof, an extract of Citrus limon and an extract of Azadirachta indica (Neem) effective in the prevention and/or treatment of vagina...  
WO/2021/260986A1
This testicular function improving agent includes microparticles derived from a culture supernatant of dental pulp-derived stem cells, adipose-derived stem cells, or immortalized stem cells of these two, and the testicular function impro...  
WO/2021/260966A1
The purpose of the present invention is to identify a new chemical substance that participates in helper T cell differentiation, to identify the generation pathways for the chemical substance, and to develop a drug targeting the same. It...  
WO/2021/258614A1
A vaginal gel preparation and a preparation method therefor, with the vaginal gel preparation comprising a carrier and a therapeutic gene; and the vaginal gel preparation further comprises a hydrophilic polymer material modified montmori...  
WO/2021/257179A1
A composition having gel-like consistency contains metronidazole, terconazole, a physiologically acceptable thickener and water. The composition is useful for treating bacterial vaginosis as well as vulvovaginal candidiasis.  
WO/2021/253742A1
An application of Wubi Chinese yams pill in the preparation of a drug for the treatment of premature ovarian insufficiency, wherein the pill consists of Chinese yam, desertliving cistanche, Chinese magnoliavine fruit, Chinese dodder seed...  
WO/2021/248767A1
Disclosed are a class of compounds for increasing the sensitivity of PCa drug-resistant cells to an antagonist and the use thereof. The structural formula of the compounds is formula I. After enzalutamide and such compounds are co-cultur...  
WO/2021/251340A1
The present invention is achieved by characterizing a molecular mechanism involved in the inter-species difference in the efficacy of EGFR-TKI, and thereby focusing on the role of IL-26, which is present in humans but not in mice. The pr...  
WO/2021/252761A2
Disclosed herein are monomeric and oligomeric compound embodiments for use as contraceptive agents. Monomeric compound embodiments disclosed herein comprise substituents that facilitate the ability of the compounds to exhibit progestogen...  
WO/2021/250289A1
The invention relates to a strain of the Lactobacillus salivarius species deposited in the Spanish Type Culture Collection (CECT) with accession number 5713 or a mutant thereof for use in the treatment and/or prevention of infertility or...  
WO/2021/247571A1
Compositions and methods for treating patients are disclosed. An example composition may include a vaginal microbiota composition. The vaginal microbiota composition may include a mixture of bacteria. The mixture of bacteria may include ...  
WO/2021/244634A1
The present invention provides an imidazopyridine compound and use thereof. Specifically, the present invention provides a compound represented by formula I, a tautomer, a stereoisomer, a hydrate, a solvate, a pharmaceutically acceptable...  
WO/2021/246779A1
The present invention relates to an amide derivative synthesized using probenecid and arginine as reactants, a pharmaceutical composition comprising same for preventing, ameliorating, or treating heart failure, and a method for synthesiz...  
WO/2021/239892A1
The present invention relates to methods of treating a condition wherein NO has a beneficial effect, wherein such treatment comprises administering certain mono- and/or bis nitrosylated propanediols, including compositions and formulatio...  
WO/2021/239961A1
The present invention relates to improved assisted reproductive technology for women predicted to have a high ovarian response to controlled ovarian stimulation that comprise targeting a threshold serum hCG level by the final day of stim...  
WO/2021/239727A1
The present invention concerns a compound of formula (I), in particular as LIMK and/or ROCK kinases inhibitors. The present invention also concerns these new inhibitors for use for the treatment of a condition selected in the group consi...  
WO/2021/242913A1
A formulation is for use in enhancing permeation of vardenafil across a nasal mucosal membrane. The formulation includes vardenafil and an organic-aqueous solvent, which includes an alcohol, a polyether, diethylene glycol monoethyl ether...  
WO/2021/238698A1
A traditional Chinese medicine composition and a traditional Chinese medicine sachet helping to boost mood, and an application thereof. The active components of the traditional Chinese medicine composition comprise the following raw mate...  
WO/2021/237322A1
The present application pertains to the medical sector and comprises a biodegradable implant containing tadalafil in a polymer matrix. Said implant is inserted into the subcutaneous layer of the patient and provides continuous release of...  
WO/2021/235977A1
The group of inventions relates to the field of medicine and the chemical and pharmaceutical industry, more particularly to a method for treating endometriosis and a pharmaceutical composition for realizing same. The method for treating ...  
WO/2021/234271A1
The present invention relates to the use of a combination of a yeast of the species Saccharomyces cerevisiae, resveratrol and a curcuma extract for use in the treatment of a subject suffering or likely to suffer from endometriosis. The c...  
WO/2021/228236A1
Provided are a deuterated tetrahydrothieno[3,4-d]pyrimidinedione compound as represented by formula (I) and a pharmaceutical composition containing the compound, or a crystal form, a pharmaceutically acceptable salt, a hydrate or a solva...  
WO/2021/231018A1
Described, among other things, are dosage form for administration to a subject, the dosage forms having at least eight phytonutrients selected from resveratrol, berberine, epigallocatechin gallate, quercetin, dandelion root extract powde...  
WO/2021/224198A1
The invention relates to an oral dosage form of mifepristone of mifepristone oral formulation characterised in that said formulation comprises an amount selected from the group consisting of 75mg, 150 mg or 300 mg mifepristone, and said ...  
WO/2021/223346A1
An application of a yam protein extract in preparation of a medication for treating erectile dysfunction. The yam protein extract is prepared by means of the following modes: homogenizing fresh yam with distilled water in an amount of 8-...  
WO/2021/223966A1
The present invention relates to new uses and methods of treatment. More specifically, the invention relates to new uses of histone deacetylase inhibitors (HDACI) such as valproic acid (VPA), for enhancing in vitro fertilization (IVF) in...  
WO/2021/224153A1
The present invention relates to pharmaceutical, dietary and/or food compositions exerting the ability to activate the endogenous production of hydrogen sulfide (H2S) so to feed the redox buffer capacity and to boost the natural ability ...  
WO/2021/221587A1
The present invention relates to a probiotic oil combination containing Lactobacillus rhamnosus, Lactobacillus gasseri, Lactobacillus acidophilus, Lactobacillus delbrueckii, Lactobacillus fermentus, Lactobacillus casei, Lactobacillus bre...  
WO/2021/219581A1
The present invention presents new and innovative methods and systems for personalized, real-time diet and lifestyle recommendations for users that are seeking to improve their own fertility. In a preferred embodiment, the present invent...  
WO/2021/218964A1
Use of an extract from Coriolus versicolor for the manufacture of a composition for the prevention and/or treatment of a vaginal or cervical disorder which is caused by an infectious agent, wherein the prevention or treatment comprises v...  
WO/2021/215364A1
[Problem] To provide a medicament, etc., capable of preventing or treating intrauterine infection. [Solution] Intrauterine infection can be prevented or treated by orally administering silicon fine particles or placing the silicon fine p...  
WO/2021/213358A1
Provided in the present invention are boron-containing compounds as represented by formula (I) or pharmaceutically acceptable salts thereof, pharmaceutical compositions including same, and an application of serving as a selective estroge...  
WO/2021/209591A1
The present invention relates to a combined oral contraceptive with a reduced risk for side effects, including a reduced risk for QT interval prolongation, a reduced risk for testosterone decrease and a reduced risk for elevated C-reacti...  
WO/2021/209471A1
The invention relates to an oral thin film, comprising a polymer matrix and ulipristal acetate as an active agent, wherein ulipristal acetate is dispersed in the polymer matrix and the polymer matrix is a matrix of water-soluble polymer ...  

Matches 401 - 450 out of 27,402